miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 5, 2026

26 Top Dividend Stocks to Buy and Hold in 2026

View original at finance.yahoo.com
26 Top Dividend Stocks to Buy and Hold in 2026 Key Points Top dividend stocks for 2026 include many that offer ultra-high yields of over 6%…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • UnitedHealth Group's stock could bounce back in 2026 after struggling in 2025

    80% confidence

  • Enbridge is the most intriguing stock in the energy group

    80% confidence

  • Top dividend stocks for 2026 include many that offer ultra-high yields of over 6%

    80% confidence

  • Alphabet checks off nearly every box in the AI arena, with a top-three cloud platform, a leading large language model (LLM), and AI chips that are gaining market momentum

    80% confidence

  • Stock Advisor's total average return is 966% compared to 194% for the S&P 500

    80% confidence

  • Identified 10 best stocks for investors to buy now, and Alphabet wasn't one of them

    80% confidence

  • AbbVie has roared back after facing patent cliff with Humira and is one of the best healthcare stocks on the market for income investors

    80% confidence

Data points we hold from this source

AbbVie Inc. · market cap405 billion_USD
The Coca-Cola Company · market cap301 billion_USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
26 Top Dividend Stocks to Buy and Hold in 2026 — Source | Via News | es.VIA.NEWS